Look at BOLD they had probably a 600M market cap BEFORE dosing their first patient in MTM. I put some value on preclinical programs and their partnerships.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.